Maria Ohle is a content creator spanning multiple subjects. She cites cannabis, business, and culture as her forte’s. Maria holds a degree in Drama and English and has a Diploma in digital multimedia. After two years of writing and working in Vancouver, Canada, she has returned home to Ireland to further her career. She is a dab hand at design as well as art and considers music to be man’s greatest invention.
Bitcoin is currently on a bull run that has seen it pack on over 65% in the last four months. Such gains mean the digital asset has more than tripled in value this year; recently, ... [Read]
A biotechnology company firmly on the radar is Cara Therapeutics (NASDAQ:CARA). The US-based drug developer was recently successful in its trialing of lead candidate Korsuva. At the end of May, CARA stock popped as the ... [Read]
Investors like biotechnology stocks for their explosive growth potential. Smaller biotechs usually don’t have approved products on the market yet, and this keeps investors on their toes. Because candidate drugs that become approved translate into ... [Read]
Small-cap biotechnology firm, Genfit (NASDAQ:GNFT), is climbing 2% in pre-market trading. After hitting a recent lull, is Genfit stock about to break out? Let’s check this out. Genfit Stock The French biotech company uplisted to ... [Read]
Zynga (NASDAQ:ZNGA) is one of the most watched low-capped shares on the market. The makers of the once-chart-topping mobile game Farmville saw a resurgence in recent months. But in the last week shares have declined. Currently, ... [Read]
Selling for less than $3 at present, Orion Energy Systems Inc. (NASDAQ:OESX) is a small-cap play in lighting and energy management. Shares under $5 are classed as penny stocks, which are often highly volatile and ... [Read]
With a market cap of $232 million USD, Chinese automaker Kandi Technologies Group (NASDAQ:KNDI) is a small-cap play in the popular Electric Vehicles (EV) market. KNDI stock currently sells for $4.42 USD but earlier in the year, ... [Read]
There are several reasons biotechnology stocks are an investor favorite. One of those reasons is that this is a vast sector. Here, companies great and small develop the next generation of treatments and medical advancements that ... [Read]
Disruptive stocks are often the ones that will return big. And in RDFN stock’s case, it is definitely disrupting the massive $31.8 trillion US housing market. In recent weeks, shares of the online real estate ... [Read]
At $7.80 USD on the NASDAQ, TELL stock is on the lower side of what these shares have fetched this year. At the highest in April, stock sold for $11.24. There has been market-wide anticipation ... [Read]